November 26, 2025, PITTSBURGH PA – RareMed, the nation’s leader in patient support and patient access solutions for complex therapies, is thrilled to announce it has been recognized by the Pittsburgh Business Times as the Fastest Growing Company in the City of Pittsburgh. Presented at the publication’s annual Fast 50 awards, this prestigious accolade celebrates the remarkable growth achieved by RareMed between 2022 and 2024, and represents RareMed’s fourth consecutive year as a finalist in the regional competition. However, this is not a story of rapid expansion—instead, it’s a testament to controlled, strategic growth driven by the right people, the right partners, the right forethought, and the right values.
Nearly two dozen RareMed team members were present at the Rivers Casino near Downtown Pittsburgh for the Pittsburgh Business Times’ award ceremony. When President Dr. Douglas Gebhard took the stage to deliver remarks, his tone was appreciative and humble, as he discussed RareMed’s commitment to growing the right way. He highlighted how RareMed’s growth is merely a byproduct of a carefully orchestrated process that aligns with its mission to enhance patient care. By focusing on patient satisfaction, team satisfaction, and controlled partner selection, RareMed has been able to achieve noteworthy growth metrics without diluting quality, culture, or reputation.
“I am so proud of what this team has been able to achieve since the company was founded seven years ago,” said RareMed Chairman & CEO Dr. Gordon Vanscoy. “We are proud to have developed a playbook for success centered around delivering uncompromising care to patients suffering from the most complex of conditions.”
From 2022 to 2024, RareMed achieved revenue growth of 359%, or a 189% compound annual growth rate, which was enough to earn the company the #1 spot. A perennial winner, RareMed achieved rankings of #6, #20, and #9 in 2022, 2023, and 2024 respectively.
“Though we’re proud of our growth, we don’t judge ourselves on our growth,” said RareMed President Dr. Douglas Gebhard. “Our focus is on the work that will win us awards for patient satisfaction, or national recognition for the quality of our culture. We’re humbled to achieve this honor by doing it the right way—focusing on our reputation for care, and letting the work speak for itself.”
RareMed was recently named MMIT’s Patient Choice Award winner for 2025, after delivering the highest average patient satisfaction scores of any specialty pharmacy-related entity for the past three years, including an impressive, perfect 100-point net promoter score in Q1 2025. RareMed has also been a perennial finalist in USA Today’s national Top Workplaces competition, Newsweek/WSJ’s national Most Loved Workplaces competition, as well as the Pittsburgh Business Times’ own Best Places to Work competition, taking first place in its size category in 2022.
Following the Fast 50 ceremony, the Pittsburgh Business Times released an inspiring article about RareMed’s reputation-focused rise. Evan Rosenberg, Market President and Publisher at the Pittsburgh Business Times, commented, “RareMed’s success has been remarkable. The company’s growth that placed them at number one on this year’s Fast 50, is clearly a result of a commitment to excellence and achievement. We can’t wait to see what comes next for this Pittsburgh success story!”
Dr. Vanscoy added, “We’re proud to work with the Pittsburgh Business Times to come together to support economic drivers in our city. We’re humbled to be surrounded by so many influential and innovative leaders in the region. As always, I’ve challenged our team to work to repeat this success by doing things the right way: taking the right opportunities with the right partners, and investing in our growing, talented team. If we continue to focus on our reputation for patient care, growth will come.”
The Essence of Controlled Growth
Strategic Program Development
The foundation of RareMed’s success lies in our ability to develop programs that address the unique needs of patients and healthcare providers. We understand that each therapeutic area requires a tailored approach, and we have invested in creating specialized programs that deliver tangible benefits. By focusing on patient-centric solutions, we have fostered trust and loyalty among our partners, paving the way for sustainable growth.
Our programs are designed with foresight, ensuring they are scalable and adaptable to the evolving healthcare landscape. Whether it’s our innovative oncology program that accelerates access to therapies or our comprehensive education initiatives that empower patients, each program is crafted to enhance patient outcomes and support healthcare providers in delivering exceptional care.
Empowering People
At the heart of RareMed’s growth story is our dedicated team of professionals. We recognize that our people are our greatest asset, and we have invested in building a workforce that embodies our values. Our team comprises industry experts who bring a wealth of knowledge and experience, enabling us to navigate the complexities of healthcare with agility and insight.
We foster a culture of continuous learning and development, empowering our team members to grow alongside the company. By providing opportunities for professional growth and creating an environment where innovation is encouraged, we ensure that our people are equipped to drive RareMed’s success. This commitment to our workforce is reflected in our ability to attract and retain top talent, further fueling our growth trajectory.
Thoughtful Forethought
RareMed’s growth is not a result of happenstance but of careful planning and foresight. We understand the importance of anticipating future trends and challenges in the healthcare industry. Our leadership team is committed to staying ahead of the curve, leveraging data-driven insights to inform our strategic decisions.
This proactive approach allows us to identify opportunities for growth and innovation before they become apparent to others. By aligning our strategies with emerging trends, we position RareMed as a leader in patient access solutions, setting new standards for excellence in the industry. Our foresight ensures that we are not only growing rapidly but also sustainably, with a clear vision for the future.
Values-Driven Expansion
At the core of RareMed’s growth is a steadfast commitment to our values of positivity, integrity, dedication, culture, quality, innovation and GROWTH. We believe that growth should never come at the expense of our principles, and we are dedicated to maintaining the highest standards of ethics and integrity in all our endeavors. Our values guide every decision we make, ensuring that our growth is aligned with our mission to improve patient care and access.
We pride ourselves on our ability to balance rapid expansion with a commitment to quality and compassion. Our values-driven approach has earned us the trust of patients, healthcare providers, and partners, fostering long-term relationships that contribute to our sustained growth. By staying true to our values, we ensure that our success is not only measured in numbers but also in the positive impact we have on the lives of those we serve.
Celebrating Success
Winning the Pittsburgh Business Times “Fast 50” award as the #1 company is a significant milestone for RareMed, and it serves as a testament to the hard work and dedication of our entire team. This recognition is a celebration of our achievements and a reminder of the potential that lies ahead.
As we look to the future, we remain committed to driving innovation and excellence in patient care. Our growth journey is far from over, and we are excited to continue expanding our reach and impact in the healthcare industry. With a focus on strategic program development, empowering people, thoughtful forethought, and values-driven expansion, RareMed is poised for continued success.
We are grateful to the Pittsburgh Business Times for recognizing our efforts and to our team for their unwavering support. Together, we will continue to pave the way for a brighter future in patient access solutions, ensuring that every patient receives the care and support they deserve.
RareMed’s recognition as the #1 “Fast 50” award winner is a testament to the power of controlled growth. By aligning our strategies with our mission and values, we have achieved remarkable success while staying true to our commitment to patient care. As we celebrate this achievement, we look forward to the opportunities and challenges that lie ahead, confident in our ability to continue making a meaningful impact in the healthcare industry.